53(top 100%)
PR articles
20.8K(top 1%)
PR citations
41(top 100%)
PR h-index
44(top 100%)
h-index
60
documents
25.6K
doc citations
3.0K
citing journals
100
times ranked

Publications

53 PR articles • 21,528 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | PR Citations
#ArticleIFPR CitationsLinks
1Targeting the tumour vasculature: from vessel destruction to promotion
Nature Reviews Cancer, 2024, 24, 655-675
61.899Citations (PDF)
2High endothelial venules in cancer: Regulation, function, and therapeutic implication
Cancer Cell, 2023, 41, 527-545
38.582Citations (PDF)
3Multiomics and spatial mapping characterizes human CD8 <sup>+</sup> T cell states in cancer
Science Translational Medicine, 2023, 15,
12.767Citations (PDF)
4LGL1 binds to Integrin β1 and inhibits downstream signaling to promote epithelial branching in the mammary gland
Cell Reports, 2022, 38, 110375
6.413Citations (PDF)
5Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis
Nature Communications, 2022, 13,
13.946Citations (PDF)
6Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
Cancer Cell, 2022, 40, 1600-1618.e10
38.5135Citations (PDF)
7The metabolism of cancer cells during metastasis
Nature Reviews Cancer, 2021, 21, 162-180
61.8816Citations (PDF)
8High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer
Frontiers in Immunology, 2021, 12,
5.179Citations (PDF)
9Peptide-guided nanoparticles for glioblastoma targeting
Journal of Controlled Release, 2019, 308, 109-118
11.192Citations (PDF)
10Tumors vs. Chronic Wounds: An Immune Cell's Perspective
Frontiers in Immunology, 2019, 10,
5.168Citations (PDF)
11Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis
Annual Review of Physiology, 2019, 81, 535-560
17.259Citations (PDF)
12Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
Journal of Pathology, 2018, 245, 209-221
5.0104Citations (PDF)
13A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma
Nature Cell Biology, 2018, 20, 1203-1214
16.9130Citations (PDF)
14Consensus guidelines for the use and interpretation of angiogenesis assays
Angiogenesis, 2018, 21, 425-532
7.9544Citations (PDF)
15The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer
Seminars in Cancer Biology, 2018, 52, 107-116
14.179Citations (PDF)
16Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Science Translational Medicine, 2017, 9,
12.7712Citations (PDF)
17Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Proceedings of the National Academy of Sciences of the United States of America, 2017, 114,
7.681Citations (PDF)
18Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors
Oncotarget, 2017, 8, 99207-99208
1.710Citations (PDF)
19Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations
Cold Spring Harbor Symposia on Quantitative Biology, 2016, 81, 21-29
1.67Citations (PDF)
20Glioblastoma: Defining Tumor Niches
Trends in Cancer, 2015, 1, 252-265
10.6436Citations (PDF)
21Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
Cell Reports, 2015, 11, 577-591
6.4155Citations (PDF)
22Intertwined regulation of angiogenesis and immunity by myeloid cells
Trends in Immunology, 2015, 36, 240-249
10.6146Citations (PDF)
23HR‐MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer
NMR in Biomedicine, 2014, 27, 1361-1370
2.429Citations (PDF)
24Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
Molecular Cancer Therapeutics, 2014, 13, 996-1007
1.861Citations (PDF)
25Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma
CNS Oncology, 2013, 2, 49-65
2.4127Citations (PDF)
26Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
Clinical Cancer Research, 2013, 19, 1773-1783
6.9193Citations (PDF)
27VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Cancer Cell, 2012, 22, 21-35
38.5536Citations (PDF)
28Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors
Cancer Cell, 2011, 20, 328-340
38.5214Citations (PDF)
29Tumor microenvironment and progression
Journal of Surgical Oncology, 2011, 103, 468-474
1.6162Citations (PDF)
30Non-Stem Cell Origin for Oligodendroglioma
Cancer Cell, 2010, 18, 669-682
38.5221Citations (PDF)
31Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Cancer Cell, 2009, 15, 220-231
38.52,237Citations (PDF)
32Modes of resistance to anti-angiogenic therapy
Nature Reviews Cancer, 2008, 8, 592-603
61.82,762Citations (PDF)
33miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
BMC Medicine, 2008, 6,
7.5861Citations (PDF)
34HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
Cancer Cell, 2008, 13, 206-220
38.51,102Citations (PDF)
35Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM
Neuro-Oncology, 2008, 10, 254-264
1.1108Citations (PDF)
36Chapter 3 Bone Marrow–Derived Vascular Progenitors and Proangiogenic Monocytes in Tumors
Methods in Enzymology, 2008, , 53-82
2.13Citations (PDF)
37Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
PLoS Medicine, 2008, 5, e19
8.5409Citations (PDF)
38HIFα induces the recruitment of bone marrow‐derived vascular modulatory cells to regulate tumor angiogenesis
FASEB Journal, 2008, 22,
0.70Citations (PDF)
39Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents
Cancer and Metastasis Reviews, 2006, 25, 243-252
7.227Citations (PDF)
40The bone marrow constitutes a reservoir of pericyte progenitors
Journal of Leukocyte Biology, 2006, 80, 677-681
3.0120Citations (PDF)
41Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
Blood, 2005, 105, 1094-1101
4.2198Citations (PDF)
42PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
Nature Cell Biology, 2005, 7, 870-879
16.9541Citations (PDF)
43Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
Cancer Cell, 2005, 8, 299-309
38.51,538Citations (PDF)
44The role of pericytes in blood-vessel formation and maintenance
Neuro-Oncology, 2005, 7, 452-464
1.11,412Citations (PDF)
45The hypoxic response of tumors is dependent on their microenvironment
Cancer Cell, 2003, 4, 133-146
38.5393Citations (PDF)
46Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
Cancer Cell, 2003, 4, 393-403
38.5241Citations (PDF)
47Tumorigenesis and the angiogenic switch
Nature Reviews Cancer, 2003, 3, 401-410
61.83,237Citations (PDF)
48Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation, 2003, 111, 1287-1295
10.7563Citations (PDF)
49Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation, 2003, 111, 1287-1295
10.71,130Citations (PDF)
50Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Nature Cell Biology, 2000, 2, 737-744
16.92,607Citations (PDF)
51Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects
Expert Opinion on Therapeutic Targets, 2000, 4, 609-633
0.868Citations (PDF)
52Extrinsic regulators of epithelial tumor progression: metalloproteinases
Current Opinion in Genetics and Development, 2000, 10, 120-127
3.2141Citations (PDF)
53MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
Cell, 1998, 93, 411-422
34.11,681Citations (PDF)